NCT01254617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +66 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Recurrent Laryngeal Squamous Cell Carcinoma
Explore clinical trials studying Recurrent Laryngeal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
21 public trials
8 recruiting studies
Recurrent Laryngeal Squamous Cell Carcinoma trial results
NCT01256385
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
NCT02007200
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +42 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT00458978
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +36 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
NCT05063552
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Epic Care-Dublin Dublin, California, United States
- Epic Care Partners in Cancer Care Emeryville, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
Active, Not Recruiting
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04862650
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
NCT00494182
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT00588770
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
NCT05172258
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
Active, Not Recruiting
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States